Citation data

CrossRef

Works that cite this article, indexed by Crossref.

60 resultsUpdated November 08, 2026

A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models

Nuclear Medicine and Biology 84-85 (2020)

Jules Zhang-Yin; Claire Provost; Géraldine Cancel-Tassin; Timofei Rusu; Mallaurie Penent; Camelia Radulescu; Eva Comperat; Olivier Cussenot; Françoise Montravers; Raphaële Renard-Penna; Jean-Noël Talbot; Aurélie Prignon

Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer

PLoS ONE 9(3) (2014)

Liang Kee Goh; Natalia Liem; Aadhitthya Vijayaraghavan; Gengbo Chen; Pei Li Lim; Kae-Jack Tay; Michelle Chang; John Soon Wah Low; Adita Joshi; Hong Hong Huang; Emarene Kalaw; Puay Hoon Tan; Wen-Son Hsieh; Wei Peng Yong; Joshi Alumkal; Hong Gee Sim; Jörg D. Hoheisel

Untitled

Imaging and Management of Prostate Cancer

Seminars in Ultrasound, CT and MRI 41(2) (2020)

Devaki Shilpa Sudha Surasi; Brian Chapin; Chad Tang; Gregory Ravizzini; Tharakeswara Kumar Bathala

A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer

Cancers 14(12) (2022)

Franklyn De Silva; Jane Alcorn

Molecular imaging for prostate cancer: Performance analysis of 68Ga-PSMA PET/CT versus choline PET/CT

Actas Urológicas Españolas (English Edition) 41(5) (2017)

L. Michaud; K.A. Touijer

The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms

Physiological Reviews 99(2) (2019)

Robyn Meech; Dong Gui Hu; Ross A. McKinnon; Siti Nurul Mubarokah; Alex Z. Haines; Pramod C. Nair; Andrew Rowland; Peter I. Mackenzie

Non-canonical androgen signaling pathways and implications in prostate cancer

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869(12) (2022)

Versha Dahiya; Gargi Bagchi

Untitled

Targeting SMAD3 for inhibiting prostate cancer metastasis

Tumor Biology 35(9) (2014)

Qing Xia; Chengjiang Li; Pingda Bian; Jue Wang; Shuai Dong

Molecular characterization of an MLL1 fusion and its role in chromosomal instability

Molecular Oncology 13(2) (2019)

Sreejit Parameswaran; Frederick S. Vizeacoumar; Kalpana Kalyanasundaram Bhanumathy; Fujun Qin; Md. Fahmid Islam; Behzad M. Toosi; Chelsea E. Cunningham; Darrell D. Mousseau; Maruti C. Uppalapati; Peter C. Stirling; Yuliang Wu; Keith Bonham; Andrew Freywald; Hui Li; Franco J. Vizeacoumar

Nano-based Herbal Medicine: A New Candidate for Prostate Cancer Treatment?

Current Traditional Medicine 10(7) (2024)

Tayebe Pouryousefi-koodehi; Mohammad Saeed Kahrizi; Hossein Roghani-Shahraki; Fatemeh Rezaei-Tazangi; Reza Arefnezhad; Hossein Motedayyen

The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG

PROTEOMICS 16(8) (2016)

Johana A. Luna‐Coronell; Klemens Vierlinger; Magdalena Gamperl; Johann Hofbauer; Ingrid Berger; Andreas Weinhäusel

Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk

Drug Metabolism Reviews 48(1) (2016)

Dong Gui Hu; Peter I. Mackenzie; Ross A. McKinnon; Robyn Meech

A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer

Cancers 11(9) (2019)

Sarah Fischer; Mohamed Tahoun; Bastian Klaan; Kolja M. Thierfelder; Marc-André Weber; Bernd J. Krause; Oliver Hakenberg; Georg Fuellen; Mohamed Hamed

Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities

International Journal of Molecular Sciences 23(2) (2022)

Rahaba Marima; Rodney Hull; Mandisa Mbeje; Thulo Molefi; Kgomotso Mathabe; Abdulrahman M. Elbagory; Demetra Demetriou; Zodwa Dlamini

Toma de imágenes molecular del cáncer de próstata: análisis de rendimiento de 68Ga-PSMA PET/TC frente a PET/TC colina

Actas Urológicas Españolas 41(5) (2017)

L. Michaud; K.A. Touijer

Prostate cancer and pollution: Dangerous connections

Annales d'Endocrinologie 86(3) (2025)

Sébastien Magnifico; Charlotte Hinault-Boyer; Frédéric Bost; Nicolas Chevalier

Biopolymer and Biomaterial Conjugated Iron Oxide Nanomaterials as Prostate Cancer Theranostic Agents: A Comprehensive Review

Symmetry 13(6) (2021)

Md. Abu Rayhan; Md. Sakib Hossen; Mahruba Sultana Niloy; Mozammel Haque Bhuiyan; Sudip Paul; Md. Salman Shakil

Network-based approach reveals Y chromosome influences prostate cancer susceptibility

Computers in Biology and Medicine 54 (2014)

Pegah Khosravi; Vahid H. Gazestani; Yazdan Asgari; Brian Law; Mehdi Sadeghi; Bahram Goliaei

Intrarectal Lidocaine-Diltiazem-Meperidine Gel for Transrectal Ultrasound Guided Prostate Biopsy

Anesthesiology and Pain Medicine 5(3) (2015)

Farsad Imani; Yasaman Moghaddam; Reza Shariat Moharari; Farhad Etezadi; Mohammad Reza Khajavi; Seyed Reza Hosseini

The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers

Cancers 14(22) (2022)

Dong Gui Hu; Shashikanth Marri; Julie-Ann Hulin; Ross A. McKinnon; Peter I. Mackenzie; Robyn Meech

Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1–Mediated Immune Evasion in Prostate Cancer

Cancer Immunology Research 9(7) (2021)

Hailong Ruan; Lin Bao; Zhen Tao; Ke Chen

Characterizing high-risk SPOP mutations in prostate cancer: Insights from computational analysis and protein-ligand docking

In Silico Research in Biomedicine 1 (2025)

Memona Aslam; Aman Ullah; Maqsood Ahmad; Ali Umar; Misbah Ullah Khan; Muhammad Zia Ahmad; Muhammad Saleem Khan

CURRENT PERSPECTIVES ON APPLICATIONS OF NANOPARTICLES FOR CANCER MANAGEMENT

International Journal of Pharmacy and Pharmaceutical Sciences (2023)

ROHIT R. BHOSALE; BHAGYESH U. JANUGADE; DHANASHRI D. CHAVAN; VANDANA M. THORAT

Iron Oxide Nanoparticles for Visualization of Prostate Cancer in MRI

Cancers 14(12) (2022)

Avan Kader; Jan O. Kaufmann; Dilyana B. Mangarova; Jana Moeckel; Julia Brangsch; Lisa C. Adams; Jing Zhao; Carolin Reimann; Jessica Saatz; Heike Traub; Rebecca Buchholz; Uwe Karst; Bernd Hamm; Marcus R. Makowski

Untitled

Functional role and tobacco smoking effects on methylation ofCYP1A1gene in prostate cancer

Oncotarget 7(31) (2016)

Yozo Mitsui; Inik Chang; Taku Kato; Yutaka Hashimoto; Soichiro Yamamura; Shinichiro Fukuhara; Darryn K. Wong; Marisa Shiina; Mitsuho Imai-Sumida; Shahana Majid; Sharanjot Saini; Hiroaki Shiina; Koichi Nakajima; Guoren Deng; Rajvir Dahiya; Yuichiro Tanaka

Unraveling the therapeutic potential of GANT61/Dactolisib combination as a novel prostate cancer modality

Medical Oncology 39(10) (2022)

Mohamed Youssef; Nermine Moussa; Maged W. Helmy; Medhat Haroun

The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer

Frontiers in Cell and Developmental Biology 10 (2022)

André P. Sousa; Raquel Costa; Marco G. Alves; Raquel Soares; Pilar Baylina; Rúben Fernandes

Retracted: Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch‐1 signaling pathway

APMIS 125(2) (2017)

Jingzhe Yang; Chengli Wang; Zhijie Zhang; Xiaojun Chen; Yusen Jia; Bin Wang; Tao Kong

Técnicas de imagen molecular en el cáncer de próstata: revisión de radiofármacos, modalidades y evidencia actual

Actas Urológicas Españolas 44(6) (2020)

J.M. Quesada-Olarte; M.E. Allaf; M. Alvarez-Maestro; L. Martínez-Piñeiro

Remodeling of androgen metabolism network mediated by UGT2B: a new perspective on treatment resistance in prostate cancer

European Journal of Pharmacology 1015 (2026)

YuanYuan Wang; Chenxi Tu; Hao Qin; Yingying Ma; Yukai Yang; Yinhua Xiong; Liang Peng; Lin Zhang

Positron emission tomography computed tomography in the diagnosis of prostate cancer

Karnataka Medical Journal 47 (2024)

Rashmi Umesh Angadi

Molecular imaging of prostate cancer: Review of imaging agents, modalities, and current status

Actas Urológicas Españolas (English Edition) 44(6) (2020)

J.M. Quesada-Olarte; M.E. Allaf; M. Alvarez-Maestro; L. Martínez-Piñeiroa

Inhibition of prostatic cancer growth by ginsenoside Rh2

Tumor Biology 36(4) (2015)

Qingchuan Zhang; Bin Hong; Songhua Wu; Tianli Niu

TRPM4 regulates Akt/GSK3‐β activity and enhances β‐catenin signaling and cell proliferation in prostate cancer cells

Molecular Oncology 12(2) (2018)

Alfredo I. Sagredo; Eduardo A. Sagredo; Claudio Cappelli; Pablo Báez; Rodrigo E. Andaur; Constanza Blanco; Julio C. Tapia; César Echeverría; Oscar Cerda; Andrés Stutzin; Felipe Simon; Katherine Marcelain; Ricardo Armisén

Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model

Journal of Medicinal Chemistry 64(21) (2021)

Justin J. Bailey; Melinda Wuest; Michael Wagner; Atul Bhardwaj; Carmen Wängler; Bjoern Wängler; John F. Valliant; Ralf Schirrmacher; Frank Wuest

Human Prostate Cancer Hallmarks Map

Scientific Reports 6(1) (2016)

Dipamoy Datta; Md. Aftabuddin; Dinesh Kumar Gupta; Sanghamitra Raha; Prosenjit Sen

Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling

Clinical Cancer Research 22(6) (2016)

Tao Wang; Wen Song; Yuan Chen; Ruibao Chen; Zhuo Liu; Licheng Wu; Mingchao Li; Jun Yang; Liang Wang; Jihong Liu; Zhangqun Ye; Chenguang Wang; Ke Chen

The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer

International Urology and Nephrology 51(11) (2019)

Ismail Selvi; Halil Basar; Numan Baydilli; Koza Murat; Ozlem Kaymaz

Chromatin Remodeler Mutations in Human Cancers: Epigenetic Implications

Epigenomics 6(4) (2014)

Katherine A Skulte; Lisa Phan; Susan J Clark; Phillippa C Taberlay

Untitled

Translationally Controlled Tumor Protein in Prostatic Adenocarcinoma: Correlation with Tumor Grading and Treatment-Related Changes

BioMed Research International 2015 (2015)

Bruno Jim Rocca; Alessandro Ginori; Aurora Barone; Calogera Calandra; Filippo Crivelli; Giulia De Falco; Sara Gazaneo; Sergio Tripodi; Gabriele Cevenini; Maria Teresa del Vecchio; Maria Raffaella Ambrosio; Piero Tosi

Untitled

NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer

Cancer Biology & Therapy 16(2) (2015)

Chuigong Yu; Guojun Wu; Ruixiao Li; Lei Gao; Fan Yang; Yi Zhao; Jian Zhang; Rui Zhang; Jing Zhang; Libo Yao; Jianlin Yuan; Xia Li

Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors

Cureus (2024)

Dhanashri D Chavan; Rohit R Bhosale; Vandana M Thorat; Amol S Shete; Sarika J Patil; Devkumar D Tiwari

A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line

Journal of Physiology and Biochemistry 72(3) (2016)

Kamila Domińska; Tomasz Ochędalski; Karolina Kowalska; Zuzanna E. Matysiak-Burzyńska; Elżbieta Płuciennik; Agnieszka W. Piastowska-Ciesielska

The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?

Nutrients 12(9) (2020)

Felice Crocetto; Mariarosaria Boccellino; Biagio Barone; Erika Di Zazzo; Antonella Sciarra; Giovanni Galasso; Giuliana Settembre; Lucio Quagliuolo; Ciro Imbimbo; Silvia Boffo; Italo Francesco Angelillo; Marina Di Domenico

Molecular MR Imaging of Prostate Cancer

Biomedicines 9(1) (2020)

Avan Kader; Julia Brangsch; Jan O. Kaufmann; Jing Zhao; Dilyana B. Mangarova; Jana Moeckel; Lisa C. Adams; Ingolf Sack; Matthias Taupitz; Bernd Hamm; Marcus R. Makowski

The Prognostic and Therapeutic Potential of Fragile X Mental Retardation 1 (FMR1) Gene Expression in Prostate Adenocarcinoma: Insights into Survival Outcomes and Oncogenic Pathway Modulation

International Journal of Molecular Sciences 25(13) (2024)

Salem Baldi; Bushra Amer; Fawze Alnadari; Maged AL-Mogahed; Yaqin Gao; Yaser Gamallat

Hormone resistance and neuroendocrine differentiation due to accumulation of genetic lesions during clonal evolution of prostate cancer

Molecular Biology 50(1) (2016)

D. S. Mikhaylenko; G. D. Efremov; A. V. Sivkov; D. V. Zaletaev